|Bid price||896.50||Open price||898.00|
|Ask price||897.00||Prev close||896.50|
Register now for FREE live Abcam share prices, Abcam stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Abcam Level 2 Data, indepth research tools and investor commentary for Abcam (ABC) and other London Stock Exchange equities.
Register now for FREE Abcam share price charts
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB00B6774699|
|Activites||Abcam plc is a leading provider of protein research tools and services, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.||Index||n/a|
|Latest Share Price (p)||896.50||Net Gearing (%)||-0.17|
|Market Capitalisation (£m)||1,796.58||Gross Gearing (%)||20.75|
|Shares in issue (m)||202.89||Debt Ratio||11.84|
|P/E Ratio||47.58||Debt-to-Equity Ratio||0.51|
|Total dividends per share (p)||8.91||Assets / Equity Ratio||1.26|
|Dividend Yield (%)||1.01||Price to book value||6.88|
|Dividend cover (x)||2.18||ROCE (%)||15.33|
|Earning per share (p)||18.61||EPS Growth (%)||-0.43|
|52 week high / low||909.50 / 547.00||DPS Growth (%)||8.53|
|Dec.Date||Type||Director||Pos||No. of Shares|
|03/10/2016||BUY||Lady Louise Patten||NED||12,378|
RNS Number : 5207L ABCAM Plc 03 October 2016 For immediate release 3 October 2016 ABCAM PLC ( "Abcam" or "Company" ) Total Voting Rights - Voting Rights and Capital In conformity with the Disclosure Rules and Transparency Rules, provision...
Alan Hirzel, Chief Executive Officer, has transferred in 10,538 shares in the company on the 30th September 2016 at a price of 0.00p. The Director now holds 37,438 shares. NOTE: Release of deferred award. Story provided by StockMarketWire.com Director deals data provided by...
Lady Louise Patten, Non Executive Director, bought 12,378 shares in the company on the 30th September 2016 at a price of 836.00p. The Director now holds 38,456 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
Register now for FREE Abcam company news
Abcam markets research-grade antibodies to academic and commercial users and is headquartered in Cambridge, UK, with a US office in Cambridge, Massachusetts. Its online catalogue of more than 17,000 products is supported by continually updated technical data created by the Company. * Abcam was...
Everytime I go from one page to another this stupid site logs me out. Stockwatch is particularly bad. Even when I am already logged in it asks me to log in again, and then takes me not to stockwatch but to the homepage. THIS IS INFURIATING!!! I will never pay for any service offered by this site...
Pickings a bit thin on the ground this week and I must admit that my trawl thru the S&P 500 was a bit half hearted. However, this one looks set for a trip back down after failing to make new highs, breaking suport at $52ish and forming, throughout 2002, what looks suspiciously like a shallow...
Register now for FREE Abcam share price discussions